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RNA recognition motifAlthough the adenovirus type 5 (Ad5) E1B 55 kDa protein can bind to RNA in vitro, no UV-light-induced
crosslinking of this E1B protein to RNA could be detected in infected cells, under conditions in which RNA
binding by a known viral RNA-binding protein (the L4 100 kDa protein) was observed readily. Substitution
mutations, including substitutions reported to inhibit RNA binding in vitro, did not impair synthesis of viral
early or late proteins or alter signiﬁcantly the efﬁciency of viral replication in transformed or normal human
cells. However, substitutions of conserved residues in the C-terminal segment of an RNA recognition motif
speciﬁcally inhibited degradation of Mre11. We conclude that, if the E1B 55 kDa protein binds to RNA in
infected cells in the same manner as in in vitro assays, this activity is not required for such well established
functions as induction of selective export of viral late mRNAs.l rights reserved.© 2011 Elsevier Inc. All rights reserved.Introduction
During the late phase of infection of permissive cells by species
C human adenoviruses, such as adenovirus type 5 (Ad5), large
quantities of viral late proteins are made while synthesis of cellular
proteins is inhibited (Anderson et al., 1973; Beltz and Flint, 1979). The
selective expression of viral late genes, most of which encode
structural proteins, is thought to facilitate the self assembly reactions
that produce progeny virions, while inhibition of cellular protein
synthesis has been reported to be required for efﬁcient release of virus
particles (Zhang and Schneider, 1994). Neither transcription of the
majority of cellular genes nor processing of primary transcripts is
perturbed during the late phase of infection (Babich et al., 1983; Beltz
and Flint, 1979; Flint et al., 1983; Granberg et al., 2005; Miller et al.,
2007; Yang et al., 1996; Zhao et al., 2007). Rather, viral late mRNAs are
both selectively translated and selectively exported from the nucleus.
Selective translation requires the viral L4 100 kDa protein (Hayes
et al., 1990). Translation of major late (ML) mRNAs, which carry the
common 202 nucleotide tripartite leader sequence (tpl) (Berget et al.,
1977; Chow et al., 1977), and of IVa2 mRNA is initiated by an alter-
native mechanism, cap-independent ribosome shunting (Dolph et al.,
1988; Yueh and Schneider, 1996). As this process exhibits a reduced
requirement for the cap binding complex elF4F (Huang and Schneider,
1991; Zhang and Schneider, 1994), the dephosphorylation and
inactivation of the elF4E component of this complex by the L4
100 kDa protein (Cuesta et al., 2004) inhibit synthesis of cellular, butnot of viral late, proteins. This L4 protein also stimulates initiation of
translation of viral ML mRNAs by binding simultaneously to the tpl
and the initiation factor elFG to recruit the 40S ribosomal subunit
(Xi et al., 2004).
Studies of the phenotypes exhibited bymutants of Ad5 established
that selective export of viral late mRNAs requires the early E1B 55 kDa
(Babiss et al., 1983; Pilder et al., 1986; Williams et al., 1986) and E4
Orf6 (Halbert et al., 1985) proteins and the complex (Sarnow et al.,
1984) they form in infected cells (Bridge and Ketner, 1990; Cutt et al.,
1987). These two viral proteins colocalize at the peripheral zones of
viral replication centers (Gonzalez and Flint, 2002; Ornelles and
Shenk, 1991), the sites of synthesis and initial processing of viral late
transcripts (Aspegren et al., 1998; Bridge and Pettersson, 1995;
Pombo et al., 1994; Puvion-Dutilleul et al., 1994). Such colocalization
is necessary for efﬁcient export of late mRNAs, as mutations that
prevent synthesis of the E4 Orf6 protein or binding of E1B 55 kDa to
this E4 protein lead to impaired export of viral late mRNAs and
mislocalization of the E1B 55 kDa protein in infected cell nuclei
(Gonzalez and Flint, 2002; Ornelles and Shenk, 1991). The E1B and E4
Orf6 proteins associate not only with one another but also the cellular
proteins cullin 5, elongins B and C, and Rbx1 to form an infected cell-
speciﬁc E3 ubiquitin ligase (Harada et al., 2002; Querido et al., 2001).
The E4 Orf6 protein binds to elongin C and is thought to direct
assembly of the ligase, whereas different residues within the E1B
55 kDa protein have been implicated in recognition of different sub-
strates (Blanchette et al., 2004; Schwartz et al., 2008). The substrates
identiﬁed to date are all cellular proteins, p53 (Harada et al., 2002; Luo
et al., 2007; Querido et al., 2001), the MreII and Nbs1 components of
the MRN double strand DNA break recognition complex (Carson et al.,
2003; Stracker et al., 2002), DNA ligase IV (Baker et al., 2007), and
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protein that blocks assembly of the infected cell-speciﬁc E3 ubiquitin
ligase (the Ad E3 ubiquitin ligase) was observed to impair viral late
mRNA export to the same degree of detection of E4 Orf6 (Blanchette
et al., 2008). Furthermore, synthesis of a dominant negative deriva-
tive of cullin 5 in infected HeLa cells induced decreases in export of
viral late mRNAs from the nucleus and in viral late protein synthesis
(Woo and Berk, 2007). These observations implicate the activity of the
Ad E3 ubiquitin ligase in regulation of mRNA export during the late
phase of infection. However, the relevant substrate(s) has not been
identiﬁed, in part because the cellular pathway responsible for export
of viral late mRNAs was not known.
The Ad5 E1B 55 kDa protein contains a leucine-rich nuclear export
signal (NES) that directs its nuclear export via the exportin-1 (Crm-1)
export receptor and shuttling between the nucleus and cytoplasm
(Dobbelstein et al., 1997; Dosch et al., 2001; Kratzer et al., 2000). In
uninfected cells, this receptor is responsible for nuclear export of
proteins that contain an NES and of small RNAs bound to them
(Gorlich and Kutay, 1999; Stutz and Rosbash, 1998; Weis, 1998).
However, exportin-1 is subverted for export of viral unspliced and
partially spliced RNAs in human immunodeﬁciency virus type
1-infected cells by the HIV-1 Rev protein, which both contains an
NES and binds to a speciﬁc sequence in the viral RNAs (Fischer et al.,
1995; Fornerod et al., 1997; Malim et al., 1991). Despite the presence
of an NES in the E1B 55 kDa protein, viral late mRNAs are not exported
via the exportin-1 receptor. Inhibition of this receptor by the drug
leptomycin B or an NES-containing, cell-permeable peptide did not
impair synthesis of viral late proteins (Carter et al., 2003; Rabino et al.,
2000) or the export of viral late mRNAs (Flint et al., 2005). Further-
more, substitutions that prevent recognition of the E1B NES by
exportin-1 had no effect on export of the late ﬁber mRNA or viral
replication (Kindsmuller et al., 2007). Themajor receptor for export of
mRNAs from the nucleus of all eukaryotes examined is the Nxf1 (Tap)
protein, which functions as a heterodimer with Nxt1(see Carmody
and Wente, 2009; Erkmann and Kutay, 2004; Kohler and Hurt, 2007;
Reed and Cheng, 2005 for reviews). We have reported recently that
inhibition of production of Nxf1 by RNA interference under conditions
that do not impair production of the E1B 55 kDa protein reduced the
efﬁciency of viral late mRNA export (Yatherajam et al., 2011).
Nxf1 was originally identiﬁed by virtue of its binding to a speciﬁc
RNA sequence, the constitutive transport element, which directs
export of unspliced RNA of the simple retrovirus, Mason–Pﬁzer
monkey virus (Kang et al., 2000). Nevertheless, Nxf1 does not interact
directly with cellular mRNAs but rather recognizes its export sub-
strates indirectly by binding to RNA-binding adaptor proteins, such as
Ref/Aly, and speciﬁc Ser/Arg-rich (SR) proteins (Carmody andWente,
2009; Huang and Steitz, 2005; Kohler and Hurt, 2007; Reed and
Cheng, 2005). The efﬁcient export of viral late mRNAs with
concomitant inhibition of cellular mRNA export could therefore be
explained by production of an RNA-speciﬁc adaptor that sequesters
Nxf1 with viral mRNA to block export of cellular mRNAs from the
nucleus. The E1B 55 kDa protein interacts with the cellular RNA
binding protein E1B-AP5 (Gabler et al., 1998), which has been
reported to associate with Nxf1 (Bachi et al., 2000). Overproduction of
E1B-AP5 in infected cells led to increases in the cytoplasmic concen-
tration of both viral ML and cellular actin mRNAs (Gabler et al., 1998).
However, it was not established that mRNA export was altered, and
E1B-AP5 was reported subsequently to regulate transcription
(Kzhyshkowska et al., 2003). Furthermore, the E1B 55 kDa insertion
mutation A143 (Yew et al., 1990) induces a substantial reduction in
the efﬁciency of viral late mRNA in both normal and transformed
human cells (Gonzalez et al., 2006; Gonzalez and Flint, 2002) but does
not affect binding of the E1B 55 kDa protein to E1B-AP5 (Gabler et al.,
1998). Another possible candidate adapter for Nxf1-dependent
export of viral late mRNAs is the E1B 55 kDa protein itself; this
protein has been reported to bind to RNA in vitro and to containan RNA-recognition motif (RRM) required for such binding (Horridge
and Leppard, 1998). We therefore examined RNA-binding by the
E1B protein in infected cells and the functional role of the RNA
recognition motif.
Results
Binding of the E1B 55 kDa protein to RNA in Ad5-infected cells
In one previous study of the RNA binding properties of the E1B
55 kDa protein, non-speciﬁc binding of the viral protein synthesized
in Escherichia coli was detected by electrophoretic mobility shift and
ﬁlter-binding assays (Horridge and Leppard, 1998). Substitutions in
an RNP1 consensus sequence of an RNA recognition motif (RRM, also
known as the RNP motif) identiﬁed in the E1B protein inhibited such
in vitro RNA-binding activity (Horridge and Leppard, 1998). Neither
RNA binding by the E1B 55 kDa protein in Ad5-infected cells nor
the importance of the RNP1 motif has been investigated. We there-
fore attempted to examine binding of the E1B 55 kDa protein to RNA
in infected cells by using UV light-induced cross-linking of protein
to RNA.
HeLa cells infected with 20 pfu/cell Ad5, typically for 18 h, were
exposed on ice to 254 nm UV light for various periods, and nuclear
lysates prepared and treated with RNase T1 as described in Materials
and methods. The E1B 55 kDa protein was then immunoprecipitated
using monoclonal antibody 2A6 (Sarnow et al., 1982) IgG and protein
A/G agarose beads. Any RNA fragments that were covalently attached
to the immunoprecipitated protein were indirectly labeled with [
32
P],
by ligation of their 3′ ends to [
32
P]-labeled pCp, as described in
Materials and methods. After extensive washing of the bead-bound
material, proteins were eluted as described in Materials and methods,
prior to SDS–polyacrylamide gel electrophoresis, transfer of proteins
to nitrocellulose membranes, and autoradiography followed by
immunoblotting to detect the E1B 55 kDa protein. To provide a posi-
tive control, the same assay was applied in parallel to the viral L4
100 kDa protein, which can be readily crosslinked to RNA in Ad5-
infected cells (Adam and Dreyfuss, 1989). One example of the results
obtained in numerous attempts to crosslink the E1B 55 kDa protein to
RNA, in this case, by exposure of infected cells to UV light for 4 min, is
shown in Fig. 1.
Labeled RNA attached to the L4 100 kDa protein was observed
speciﬁcally in Ad5-infected cells (Fig. 1A, lines 5 and 6, black arrow),
as anticipated from the results of a previous study (Adam and
Dreyfuss, 1989). A protein labeled at low efﬁciency by RNA transfer
that migrated slightly more slowly than the 50 kDa molecular mass
marker was also evident in infected cell samples (Fig. 1A, lanes 1, 3,
and 5, gray arrow). However, this species was present regardless of
whether infected cells had been exposed to UV light (Fig. 1A, lanes 1
and 3) and in both E1B 55 kDa and L4 100 kDa immunoprecipitates
(Fig. 1A, lanes 3 and 5). Furthermore, it migrated slightly more
rapidly than the E1B 55 kDa protein detected by immunoblotting
of the same gel after autoradiography (Fig. 1B, lanes 1 and 3). Similar
results were obtained when Ad5-infected cells were exposed to
UV light for longer periods or were treated later in the infectious
cycle, when greater quantities of viral RNAs are synthesized (data
not shown).
There are several possible explanations for the failure to observe
binding of the E1B 55 kDa protein to RNA in infected cells in these
experiments. The efﬁciency with which UV light induces formation of
photo-adducts between proteins and nucleic acids depends on
several parameters, including the nucleotide composition of the
nucleic acids, and the proximity and geometry of appropriate amino
acids and bases in the protein–nucleic acid complex (see Chodosh,
2001; Zhang et al., 2004). The atomic structure of any interface
between the E1B 55 kDa protein and RNA might therefore preclude
efﬁcient UV light-induced crosslinking. It is also possible that
Fig. 1. TheE1B55 kDaprotein cannot becross-linked toRNA inAd5-infectedcells.HeLa cellswere infectedwith20 pfu/cellAd5 for18 h (I) ormock-infected (M)andeitherexposed (+)or
not exposed (−) to 254 nm light for 4 min. The E1B 55 kDa or the L4 100 kDa protein was immunoprecipitated (IP) from nuclear lysates, and any covalently attached RNA fragments
indirectly labeled with [
32
P], as described in Materials and methods. Following electrophoresis in an 8% SDS–polyacrylamide gel, proteins were transferred to nitrocellulose and the
membrane subjectedsequentially to autoradiography (A) and immunoblotting todetect theE1B55 kDaprotein (B). Thepositionsofmolecularmassmarkersare listedat the left ofpanel A.
The black and gray arrows at the right of panel A indicate the positions of the L4 100 kDa protein and a protein of some 50 kDa discussed in the text, respectively.
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dynamic and transient, properties that would decrease the likelihood
of formation of photo-adducts between the protein and RNA. For such
reasons, it is not possible to conclude from results like those shown in
Fig. 1 that the E1B protein does not bind to RNA in vivo.
Mutation of the E1B 55 kDa protein RNA binding motif does not impair
viral late gene expression or replication
The RRM typically comprises some 90 amino acids containing a
highly conserved RNP1 consensus sequence and a less well con-
served RNP2 sequence (Adam et al., 1986; Kenan et al., 1991;
Swanson et al., 1987). The E1B 55 kDa RRM identiﬁed by Horridge
and Leppard(1998) and the conserved secondary structure of the
RRM, an α β sandwich (Maris et al., 2005), are shown in Fig. 2A. The
viral sequence contains many of the residues typically conserved
among cellular RRMs (indicated by bold italic face in Fig. 2A) and
residues within the Ad5 E1B 55 kDa protein RNP1 and RNP2 motifs
are conserved among serotypes representative of the 6 human
adenovirus species (Fig. 2B). Structural studies have established that
amino acids that form the RNP1 beta 3 strand make direct contacts
with bases or the phosphate backbone of single-stranded nucleic
acids (Maris et al., 2005) and substitutions within the Ad5 E1B
55 kDa RNP1 sequence reduced or eliminated in vitro RNA binding
activity (Horridge and Leppard, 1998). To investigate the role of RNA
binding in viral replication, mutations resulting in two of these
substitutions, A284S and F285L (E1BSub12;Fig. 2B), were introduced
simultaneously into the E1B 55 kDa protein coding sequence in the
viral genome. It has been recognized more recently that RRMs can
also participate in protein–protein interactions to mediate interac-
tion of two such domains within a single protein or association of two
different proteins (Maris et al., 2005). In several such cases, binding
of RRMs to one another is via residues located within the C-terminal
α2 helix (Maris et al., 2005). The corresponding sequence of the Ad5
E1B 55 kDa protein contains several residues that are completely or
highly conserved among human adenoviruses (Fig. 2B). To assess the
functional importance of this conserved sequence, we designed
mutations that result in substitution of ﬁve residues within it by Ala
(E1BSub13;Fig. 2B).
The E1B 55 kDa substitution mutations were introduced into the
viral genome and mutant viruses, designated AdEasy E1BSub12 and
AdEasy E1BSub13, isolated in complementing 293 cells (Aiello et al.,
1979; Graham et al., 1977), as described in Materials and methods.The concentrations of the E1B 55 kDa protein accumulating in HeLa
cells and normal human ﬁbroblasts infected by the mutants and the
phenotypically wild-type parent were compared by immunoblot-
ting. No signiﬁcant differences in the steady state concentration of
this viral protein, relative to those of an internal β-actin control,
were observed in either HeLa cells or HFFs infected by the mutant
and the wild type viruses (Fig. 3A and B). These observations indi-
cate that neither set of substitutions reduces the stability of the E1B
55 kDa protein.
To begin to assess the effects of these mutations on viral
replication, the concentrations of additional viral proteins were
compared in transformed and normal human cells infected by the
wild-type and mutant viruses. Neither of the substitutions resulted in
impaired production of the early E2 DNA-binding protein (DBP) or of
protein V, a late structural protein, in HFFs (Fig. 3C) or HeLa cells (data
not shown). The former result is not surprising, as no effects on
synthesis of other early proteins have been observed in transformed
or normal human cells infected by E1B 55 kDa-null mutant viruses
(Harada and Berk, 1999; O'Shea et al., 2004; Pilder et al., 1986;
Williams et al., 1986). As discussed previously, viral late mRNAs are
not exported efﬁciently from the nucleus in cells infected by such
mutants (see Introduction). This defect results in a signiﬁcantly more
severe inhibition of late protein synthesis (Goodrum and Ornelles,
1999; Harada and Berk, 1999; Pilder et al., 1986;Williams et al., 1986),
in part because speciﬁc late proteins are required for late phase-
speciﬁc stimulation of transcription from the major late (ML)
promoter (Ali et al., 2007; Tribouley et al., 1994), to establish the
late pattern of alternative processing of ML pre-mRNAs (Farley et al.,
2004; Tormanen et al., 2006) or for efﬁcient translation of viral late
mRNAs (Cuesta et al., 2000; Hayes et al., 1990). Towards the end of
the late phase of infection, the activity of the Ad E3 ubiquitin ligase
also prevents activation of the RNA-dependent protein kinase Pkr,
phosphorylation of elF2α, and reduced translation of viral late mRNAs
(Spurgeon and Ornelles, 2009). The observation that the concentra-
tion of protein V is not reduced in cells infected by the mutants
therefore indicates that the E1BSub12 and E1BSub13 mutations
impair neither viral late mRNA export nor the ability of the Ad E3
ligase to block activation of Pkr.
The efﬁciency of replication of the mutant viruses was next com-
pared to that of the wild type, initially by measuring production of
infectious particles as a function of time after infection at typical
multiplicities. The kinetics of virus production were virtually identical
in HeLa cells infected with 10 pfu/cell wild type and the AdEasy
Fig. 2. The RNA recognition motif of the E1B 55 kDa protein. A) The Ad5 E1B 55 kDa protein is represented by the box at the top, with the positions of the nuclear export signal (NES)
(Dobbelstein et al., 1997; Kratzer et al., 2000), the RRM (Horridge and Leppard, 1998), and sites of sumoylation (Sumo-1) (Endter et al., 2001) and phosphorylation (P) (Teodoro and
Branton, 1997) indicated. The sequence of the RRM is shown below, with the RNP1 and RNP2motifs boxed, and amino acids conserved among RRMs indicated in bold, italic face. The
underlined amino acids are aromatic residues important for RNA binding (Maris et al., 2005). The conserved secondary structure of the RRM (Maris et al., 2005) is shown below. B)
The sequences of the E1B 55 kDa proteins of human adenoviruses of species C (Ad5 and Ad2), species A (Ad9 and Ad37), species B (Ad3 and Ad7), species D (Ad9 and Ad37), species E
(Ad4 and Ad25), and species F (Ad41) corresponding to residues 248 to 308 of the Ad5 protein were aligned using Clustal W (1.83) (Larkin et al., 2007; Thompson et al., 1994). The
sequences of the RRM are shown, with the RNP1 and RNP2motifs in bold face and the alpha2 helix in italic face. Below are indicated amino acids that are identical in all sequences (*)
or represent conservative (:) or semi-conservative (.) substitutions. The amino acid substitutions introduced by the E1BSub12 and E1BSub13 mutations are listed below.
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infected with 30 pfu/cell (data not shown). In separate experiments,
the yield of virus 44 h after low or high multiplicity infection of the
two cell types were also compared with no signiﬁcant differences
detected in HeLa cells (Fig. 4B). However, in HFFs infected at low or
high multiplicity, the yields of AdEasy E1B Sub12 were reduced 4- to
6-fold. These decreases were statistically signiﬁcant, but whether they
have biological relevance is not clear: in these cells, replication of the
E1B 55 kDa null mutant Hr6 is reduced by three orders of magnitude
(Gonzalez et al., 2006).
Contacts between RRM domains and single-stranded nucleic acids
can be made via residues only in the β-strand formed by the RNP1
motif, by amino acids in both RNP motifs, or only by RNP2 residues
(Maris et al., 2005). We therefore wished to address the question of
whether the RNP2 motif contributed to the functions or the E1B
55 kDa protein. Mutations that result in substitution of RNP2 amino
acids conserved among the E1B 55 kDa proteins of human adenovirus
(Fig. 2B) were therefore introduced into the E1BSub12 background to
create a double RNP mutant. However, this approach was not
informative, as the steady state concentration of the E1B 55 kDa
protein was reduced some 10-fold in cells infected by the double
mutant virus (data not shown).
Effects of E1B RNP mutations on degradation of substrates of the infected
cell-speciﬁc E3 ubiquitin ligase
The results of previous studies have suggested that the E1B
55 kDa protein is the substrate recognition subunit of the Ad E3ubiquitin ligase (see the Introduction). As RNA recognition motifs
can also participate in protein–protein interactions (Maris et al.,
2005), it was of interest to determine whether the substitutions in
the RNP1 motif or adjacent α2 segment of the E1B protein (Fig. 2A)
impaired degradation of proteins modiﬁed by this ligase. These
proteins include the cellular tumor suppressor p53 (Harada et al.,
2002; Luo et al., 2007; Querido et al., 2001), which is absent from, or
altered in, many lines of human tumor cells(reviewed in Hainaut and
Hollstein, 2000; Hollstein et al., 1991). Consequently, these exper-
iments were performed in normal human ﬁbroblasts. Initial
examination of the concentrations of the Ad E3 ubiquitin ligase
substrate Mre11 (Stracker et al., 2002) in the infected HFF samples
used in the analyses shown in Fig. 3B suggested that this protein was
not degraded as efﬁciently in cells infected by AdEasy E1BSub13 as
following AdEasy E1BSub12 (data not shown). To investigate this
effect more rigorously by comparison to a positive control, we
introduced a deletion of base pair 2347 in the viral genome into the
same genetic background to create the mutant AdEasy E1Δ2347, as
described in Materials and methods. This deletion, which is present
in the genome of Hr6 (Williams et al., 1986), alters only the coding
sequence of the E1B 55 kDa protein and results in premature
termination of translation a short distance downstream. Conse-
quently, no E1B 55 kDa protein (nor the predicted N-terminally
truncated derivative) can be detected in Hr6-infected cells (Gonzalez
et al., 2006; Lassam et al., 1979; Williams et al., 1986). Sequencing of
plaque-puriﬁed isolates of AdEasy E1Δ2347 conﬁrmed the presence
of this single base pair deletion, but no other mutations, in the E1B
or E1A genes.
Fig. 3. Steady state concentrations of viral proteins in wild type- and mutant virus-
infected cells. A) HeLa cells were infected with 10 pfu/cell AdEasy E1 (WT), AdEasy
E1Sub12, or AdEasy E1Sub13 for the periods indicated at the top, or mock infected (M).
Total protein extracts were prepared and the E1B 55 kDa protein and β-actin examined
by immunoblotting, as described in Materials and methods. B) As panel A, except that
HFFs were infected with 30 pfu/cell of the viruses listed at the top of panel A. C) The
viral E2 DNA binding protein (DBP) and late protein V were examined by
immunoblotting of the samples used in the experiment shown in panel B. In all panels,
the positions of molecular mass markers are indicated at the left.
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ited by Hr6, we ﬁrst compared accumulation of the E1B 55 kDa protein
in cells infected by AdEasy E1 or AdEasy E1Δ2347 by immunoblotting
after increasing periods of infection. The concentrations of the internal
controlβ-actinwere very similar in all samples (Fig. 5A). However, the
E1B 55 kDa protein could not be detected in mutant-infected cells,
even at late times when high concentrations were present in cellsFig. 4. The RRMmutations do not impair viral replication. A) HeLa cells were infected with 10
after increasing periods. The yield of intracellular infectious particles was determined as de
least three technical replicates, with the standard deviations shown by the error bars. B) Yiel
with 0.1 or 1.0 pfu/cell, and of HFFs with 3 or 30 pfu/cell wild type or mutant viruses. The aste
be signiﬁcant (P=0.005 and 8×10−6 for 3 and 30 pfu/cell, respectively) by application ofinfected by the parental wild-type virus (Fig. 5A). These observations
indicate that, as predicted from the properties of Hr6 described above,
deletion of the bp2347 from the AdEasy E1 genome prevents
production of the E1B 55 kDa protein in infected cells. When this
E1B protein cannot be made in infected cells, synthesis of viral late
proteins is impaired (Goodrum and Ornelles, 1999; Harada and Berk,
1999; Pilder et al., 1986; Williams et al., 1986), a phenotype that is
particularly dramatic in HFFs (Gonzalez et al., 2006). The effects of the
deletion on accumulation of a late structural protein, protein V, were
therefore also examined by immunoblotting. This late protein was
readily detected by 22 h after infection with AdEasy E1 and increased
considerably in concentration by 44 h (Fig. 5A). In contrast, protein V
was not observed 22 h after infection with AdEasy E1Δ2347 and
attained signiﬁcantly lower concentrations than in wild-type infected
cells by 44 h (Fig. 5A).We therefore conclude that deletion of base pair
2347 from theAdEasy E1 genome resulted in failure to produce the E1B
55 kDa protein, as predicted, and reproduced the defect in viral late
gene expression previously observed in transformed and normal
human cells infected by Hr6 and other E1B 55 kDa-null mutants
(Gonzalez et al., 2006; Goodrum and Ornelles, 1999; Harada and Berk,
1999; Pilder et al., 1986; Williams et al., 1986).
The effects of this E1B 55 kDa null mutation and the E1BSub13
substitutions on degradation of substrates of the AdE3 ubiquitin ligase
were next compared by immunoblotting. Although the concentration
of Mre11 was observed to be reduced in AdEasy E1Δ2347-infected
cells at 22 and 44 h p.i., this decrease was considerably less than in
cells infected in parallel by AdEasy E1 (Fig. 5B, lanes 1–5), as expected
(Stracker et al., 2002). The degree and rate of decline in Mre11
concentration were virtually identical in cells infected by AdEasy
E1Sub13 and the E1B-null mutant, even though the E1B 55 kDa
protein was produced efﬁciently in the former case (Fig. 5B, compare
lanes 4 and 5 with lanes 6 and 7). This phenotype indicated that the
E1BSub13 substitutions might impair interaction of the E1B with the
E4 Orf6 protein and hence the assembly of the Ad E3 ubiquitin ligase
and targeting of all known substrates for proteasomal degradation.
Alternatively, the substitutions could disrupt speciﬁcally the binding
of the E1B substrate recognition-subunit of the ligase to Mre11. To
distinguish between these possibilities, we examined the effects of the
mutations on concentrations of a second substrate, p53. Despite
accumulation to much increased concentrations by 44 h after
infection with AdEasy E1Δ2347, p53 was detected at only very low
concentrations in cells infected by either AdEasy E1Sub13 or its wild-
type parent (Fig. 5B), indicating that the E1BSub13 substitutions dopfu/cell AdEasy E1 (WT), AdEasy E1Sub12, or AdEasy E1Sub13, and samples harvested
scribed in Materials and methods. In both panels, the values represent the means of at
ds of intracellular infectious particles were determined 44 h after infection of HeLa cells
risks indicate difference between wild-type andmutant virus replication determined to
the Student's t test.
Fig. 5. Effects of the RRM mutations on degradation of Mre11 and p53. A) HFFs were infected with AdEasy E1 (WT) or AdEasy E1Δ2347 (Δ2347) for the periods indicated, or mock
infected (M). Total cell extracts were prepared and the proteins listed at the right examined by immunoblotting. B) HFFs were infected with the same wild-type and E1B 55 kDa-null
mutant or AdEasy E1Sub13 (Sub13) for the periods indicated, or mock infected (M22, M44). The proteins listed at the right were examined by immunoblotting of total cell extracts.
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AdE3 ubiquitin ligase.
Discussion
The E1B 55 kDa protein RRM is one of the few sequence motifs
associated with speciﬁc functions reported or suggested to be present
in this protein (Blackford and Grand, 2009; Flint and Gonzalez, 2003;
Horridge and Leppard, 1998). Although the integrity of the RNP1
sequence within this motif was reported to be required for in vitro
binding of the E1B protein to RNA (Horridge and Leppard, 1998), no
interaction of the E1B protein with RNA could be detected in Ad5-
infected cells by UV light-induced crosslinking (Fig. 1). This negative
result can be explained by either the fact that E1B 55 kDa protein
does not bind to RNA during the infectious cycle or properties of the
protein–RNA interaction that preclude efﬁcient crosslinking, such as a
very short lifetime or an atomic structure of the protein–RNA
interface that precludes efﬁcient crosslinking. An analysis of the
phenotypes exhibited by substitutions within the RRM, including
RNP1 substitutions reported to inhibit severely RNA binding in vitro
(Horridge and Leppard, 1998), was undertaken to help distinguish
between these possibilities. The failure of these mutations to impair
signiﬁcantly viral late gene expression (Fig. 3) or replication (Fig. 4)
indicates that, if the E1B 55 kDa protein interacts with RNA in
infected cells in the same way as it does in vitro, this activity is not
required for efﬁcient progression through the infectious cycle.
Furthermore, the absence of any defect in viral late gene expression
(Fig. 3) provides strong evidence that such RNA-binding activity does
not contribute to the E1B 55 kDa protein-dependent selective export
of viral late mRNA (see Introduction) or inactivation of Pkr (Spurgeon
and Ornelles, 2009).
The substitutions introduced into the E1B 55 kDa protein targeted
amino acids of the RNP1 sequence conserved among representatives
of all 6 human adenovirus species (E1BSub12) or included such
completely conserved residues in the C-terminal segment of the RRM
(E1BSub13) (Fig. 2B). There are several possible explanations for our
ﬁnding that replacement of these highly conserved residues had no
signiﬁcant impact on viral replication. It may be that there is
redundancy between the function fulﬁlled by the E1B RRM and one
or more additional viral proteins. An excellent example of this pheno-
menon in Ad5-infected cells is provided by E1B 55 kDa and E4 Orf6
protein-containing Ad E3 ubiquitin ligase and the E4 Orf3 protein:
either the ligase or the E4 Orf3 protein alone can inactivate com-
ponents of the MRN double strand break repair complex to a degree
sufﬁcient to protect against inhibition of viral DNA synthesis (Araujoet al., 2005; Evans and Hearing, 2005; Liu et al., 2005; Stracker et al.,
2002). Consequently, viral genome replication is impaired only when
both the Ad E3 ubiquitin ligase and the E4 Orf3 protein are not present
(Bridge and Ketner, 1989; Evans and Hearing, 2005; Jayaram and
Bridge, 2005; Mathew and Bridge, 2007). In fact, such functional
redundancy was observed in these experiments: viral late gene
expression and replication were as efﬁcient in AdEasy Sub13-infected
HFFs as in cells infected by the wild-type parent (Figs. 3 and 4), even
though these mutations impaired degradation of Mre11 to the same
degree as the absence of the E1B 55 kDa protein (Fig. 5B).
The E1B 55 kDa protein has been proposed to function as the
substrate-recognition subunit of the Ad E3 ubiquitin ligase
(Blanchette et al., 2004): it can associate with the substrates p53
(Cathomen and Weitzman, 2000; Kao et al., 1990; Liu and Green,
1994; Yew et al., 1994), components of the MRN complex (Cathomen
and Weitzman, 2000), and DNA ligase IV (Baker et al., 2007) in the
absence of the E4 Orf6 protein. A previous analysis of the effects of
insertions and substitutions in the E1B 55 kDa protein on binding to
p53 and Mre11 and their subsequent degradation indicated that the
viral protein recognizes these substrates via different sequences
(Schwartz et al., 2008). Our observation that the E1BSub13 sub-
stitutions within the C-terminal α-helix of the putative RRM impair
degradation of Mre11 but not of p53 (Fig. 5B) is consistent with this
conclusion: as p53 is degraded efﬁciently in cells infected by this
mutant (Fig. 5B), we can conclude that the E1BSub13 substitutions do
not interfere with assembly of the Ad E3 ubiquitin ligase. These
substitutions, which replace amino acids 295 to 299 with alanine, are
more N-terminal than mutations previously reported to impair
degradation of Mre11, such as insertions at residues 354, 373, and
443 (Schwartz et al., 2008). These observations suggest that amino
acids that are well separated in the primary sequence lie in close
proximity in the native E1B 55 kDa protein to form a discrete Mre11
recognition pocket or surface.
It also remains possible that the E1B 55 kDa protein RNP1 motif
and the sequence immediately C-terminal to it targeted in these
studies mediate functions of the protein that could not be detected
using the assays described here. One such function is repression of
expression of speciﬁc cellular genes in infected HFFs (Miller et al.,
2009). It has been known for some time that the E1B 55 kDa protein
can repress transcription, including p53-dependent transcription, in
in vitro and transient co-expression assays (Martin and Berk, 1998;
Teodoro and Branton, 1997; Yew and Berk, 1992; Yew et al., 1994).
Such repression has been correlatedwith the ability of the E1B protein
to cooperate with viral E1A proteins in transformation of rodent cells
(Endter et al., 2005; Teodoro and Branton, 1997; Yew and Berk, 1992).
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E1B 55 kDa-null mutants in which the Ad E3 ubiquitin ligase is not
present, p53 accumulates to high concentrations (Cardoso et al.,
2008; O'Shea et al., 2004). Nevertheless, the p53 transcriptional
program is reversed as efﬁciently in the absence of the E1B 55 kDa
protein as it is in Ad5-infected cells (Miller et al., 2007; Miller et al.,
2009). On the other hand, expression of a set of cellular genes highly
enriched for those associated with innate anti-viral and adaptive
immune responses was increased signiﬁcantly in Hr6-infected cells
(Miller et al., 2009). We have observed that viral replication is more
sensitive to inhibition by exogenous type I interferon in the absence
of the E1B 55 kDa protein (J. Qi, J. Chahal, and S.J.F., unpublished
observations), suggesting that repression of expression of host
immune defense genes by the E1B protein serves as a countermea-
sure to cellular anti-viral defense mechanisms. It will therefore be of
interest to investigate whether the RRM substitutions impact this
function of the E1B 55 kDa protein.
Materials and methods
Cells and virus
HeLa cells and primary human foreskin ﬁbroblasts (HFFs) were
maintained in monolayer cultures in DMEM (Gibco-BRL) containing
5% (vol./vol.) calf serum (Gibco-BRL) plus 5% (vol./vol.) Hyclone
bovine growth serum (Thermo Fisher Scientiﬁc) and 10% (vol./vol.)
bovine growth serum, respectively. Wild-type and mutant viruses
were propagated in 293 cells (Graham et al., 1977) and concentrations
of infectious particles determined by plaque assay on these same cells
(Williams, 1973).
A phenotypically wild-type derivative of the AdEasy genome (He
et al., 1998) that contains the complete E1A and E1B genes was
constructed by homologous recombination between pShuttle E1,
which has been described previously (Miller et al., 2009), and
pAdEasy-1 (He et al., 1998) in E. coli BJ 5183 cells. The E1BSub12
and E1BSub13 mutations that result in substitutions of amino acids
within the putative RNA recognition motif of the E1B 55 kDa protein
(Fig. 2B) were introduced into the plasmid pShuttle E1 (Miller et al.,
2009) by using the QuikChange II site-directed mutagenesis kit
(Stratagene-Agilent Technologies) as recommended by the manufac-
turer. Plasmids carrying the E1BSub13 mutations were identiﬁed by
the presence of a new restriction endonuclease cleavage site, whereas
recovery of the E1BSub12 mutations was assayed by sequencing of
the relevant region of the E1B gene. The deletion of base pair 2347
present in the E1B gene of the Ad5 mutant Hr6 was introduced into
pShuttleE1 by the same method, and plasmids carrying this muta-
tion identiﬁed by loss of an MwoI cleavage site. Recovery of the
mutations into the viral genome, isolation, plaque-puriﬁcation and
ampliﬁcation of mutant viruses in 293 cells, and conﬁrmation of the
presence of the mutations in viral DNA were as described previously
(Miller et al., 2009).
To examine viral replication, HeLa cells or HFFs in 6 well dishes
were infected with wild type AdEasy E1, Ad5E1BSub12, or Ad5E1B-
Sub13 for increasing periods, or with different multiplicities for 44 h.
Cells were harvested and washed once in PBS and resuspended in
0.125 ml/well of 0.01 M Tris–HCl, pH 7.4, containing 0.15 NaCl,
0.005 MKCl, 10 mMMgCl2, and 0.1% (wt./vol.) dextrose. After 5 cycles
of freeze-thawing and centrifugation at 500g for 10 mins at 4 °C,
concentrations of infectious particles were determined by plaque
assay on 293 cells.
Crosslinking of proteins to RNA
HeLa cells were infected with 20 pfu/cell Ad5 for 18 to 24 h, or
mock infected, and washed twice with 5 ml/10 cm dish ice-cold
phosphate-buffered saline (PBS; Gibco-BRL), prior to addition of2 ml/plate PBS. Cells on ice were then irradiated with ~4000 μW/cm2
254 nm UV light for 2–8 min using a Stratalinker 2400 UV crosslinker
(Stratagene). They were washed twice with 5 ml PBS and lysed by
incubation for 5 min at 4 °C in 0.05 M Tris–HCl, pH 7.4, containing
0.15 M NaCl, 1.5 mM MgCl2, 0.6% (vol./vol.) Nonidet P40 (NP-40),
1 mm PMSF, 1 μg/ml antipain, 2 μg/ml leupeptin, and 100 U/ml
RNasin (Promega). Nuclei were collected by centrifugation and
suspended in 0. 05 M Tris–HCl, pH 7.4, containing 0.15 M NaCl,
3 mMMgCl2, 0.4% NP-40, and the protease and RNase inhibitors listed
above, and sonicated on ice in 30 s bursts until sample viscosity was
reduced. RNase-free DNase I (Roche Applied Science) was added to a
ﬁnal concentration of 0.1 U/ml, and samples incubated for 30 min at
room temperature. RNase T1 (Ambion Inc.) was added to a ﬁnal
concentration of 0.04 U/ml prior to incubation for a further 30 min at
room temperature. Samples were centrifuged at 16,000g for 10 min at
4 °C. Supernatants were removed and pre-cleared by incubation for
1 h at 4 °C with protein A/G agarose beads (Santa Cruz Biotechnology)
that had been washed twice with 0.05 M Tris–HCl, pH 7.4, containing
0.15 M NaCl, 1 mM EDTA, 1% (vol./vol.) NP-40, 1 mM PMSF, 2 μg/ml
leupeptin, 1 μg/ml antipain, and 100 U/ml RNasin (buffer A), and
resuspended in this buffer. The beads were removed by centrifugation
at 800g for 1 min at 4 °C. The E1B 55 kDa or L4 100 kDa proteins were
then immunoprecipitated by sequential incubation of supernatants
with monoclonal antibodies 2A6 IgG (Sarnow et al., 1982) or 2100-1,
respectively (Cepko and Sharp, 1982) (overnight at 4 °C with rota-
tion), and protein A/G agarose (4 h at 4 °C with rotation) prepared as
described above. The beads were collected by centrifugation at 800g
for 1 min at 4 °C and washed twice with buffer A, twice with the same
buffer containing 0.5 M rather than 0.15 M NaCl, and twice with
0.05 M Tris–HCl, pH 7.4, containing 10 mMMgCl2 and 0.5% (vol./vol.)
NP-40 (buffer B). They were then resuspended in 0.05 M Tris–HCl, pH
8.5, containing 1 mM EDTA and incubated with 0.75 U/ml calf intes-
tinal alkaline phosphatase (Roche) for 30 min at 37 °C. After centri-
fugation as described above, beads were washed twice with 0.05 M
Tris–HCl, pH 7.4, containing 20 mM EGTA and 0.5% (vol./vol.) NP-40,
and twice with buffer B. Following resuspension in 0.05 M Tris–HCl,
pH 7.8, containing 10 mM MgCl2, 1 mM ATP, 1.6 μg bovine serum
albumen, and 1 mM dithiothreitol, samples were incubated over-
night at 4 °C with 100 μCi [
32
P]-pcp (300 Ci/mmol; Perkin Elmer) and
0.5 U/ml T4 RNA ligase 1 (New England Biolabs). Following ligation,
the beads were collected by centrifugation as described above and
washed four times with buffer B. They were then resuspended in
0.12 M Tris–HCl, pH 6.8 containing 4% (wt./vol.) SDS, 20% (vol./vol.)
glycerol, and 0.004% (wt./vol.) bromphenol blue. Proteins were
released by incubation at 100 °C for 10 min followed by centrifugation
at 15,000g for 10 min at room temperature to remove protein A/G
agarose. Proteins were subjected to electrophoresis in 8% polyacryl-
amide gels and transferred to 0.2 μm nitrocellulose membranes
(Millipore). The membranes were rinsed in PBS and exposed to
HyBlot CL™ autoradiography ﬁlm (Denville Scientiﬁc Inc.) at −80 °C
in the presence of intensifying screen. Subsequently, the E1B 55 kDa
protein was detected by immunoblotting with the 2A6 monoclonal
antibody as described (Gonzalez and Flint, 2002).
Immunoblotting
HeLa cells and HFFs were infected with 10 pfu/cell and 30 pfu/cell,
respectively, of wild-type AdEasy E1 or the AdEasy E1BSub12, AdEasy
5E1BSub13, or AdEasy E1Δ2347 mutants, for increasing periods, or
mock-infected. Cells were lysed by addition of 0.2 ml/well of a 6 well
dish of 0.06 M Tris–HCl, pH 6.8, containing 2% (wt./vol.) SDS, 10%
(vol./vol.) glycerol, 5% (vol./vol.) β-mercaptoethanol, and 0.002%
(wt./vol.) bromphenol blue. Lysates were collected and stored at
−20 °C. Prior to electrophoresis in 10% polyacrylamide gels cast and
run in 0.1 M Tris, 0.192 M glycine, pH 8.8, containing 0.1% (wt./vol.)
SDS, lysates were sonicated as described above and incubated at
16 S.E.M. Kato et al. / Virology 417 (2011) 9–17100 °C for 10 min. The viral E1B 55 kDa protein, the E2 single-
stranded DNA-binding protein, and protein V were detected by
immunoblotting with monoclonal antibodies 2A6 (Sarnow et al.,
1982), B6 (Reich and Levine, 1984), and F58#1 (Lunt et al., 1988),
respectively. The cellular Mre11 and p53 proteins were examined
using rabbit anti-Mre11 polyclonal antibodies (Novus Biologicals) and
anti-p53 mouse monoclonal antibody DO1 directly conjugated to
horse radish peroxidase (Santa Cruz). To provide internal controls, the
concentrations of β-actin were examined in parallel by using an anti-
human β-actin monoclonal antibody conjugated to horse radish
peroxidase (Abcam). Primary antibodies were visualized by enhanced
chemiluminescence (Amersham Bioscience) following binding by
anti-mouse or anti-rabbit IgG conjugated to horse radish peroxidase
(Millipore Corporation).
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